The latest report from Fore Pharma, Prostate Cancer Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Prostate Cancer market. It covers emerging therapies for Prostate Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages: The report provides Prostate Cancer pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes: The report provides Prostate Cancer pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company: The report provides Prostate Cancer pipeline products by the company.
Short-term Launch Highlights: Find out which Prostate Cancer pipeline products will be launched in the US and Ex-US till 2020.
Prostate Cancer phase 3 clinical trial pipeline products
Prostate Cancer phase 2 clinical trial pipeline products
Prostate Cancer phase 1 clinical trial pipeline products
Prostate Cancer preclinical research pipeline products
Prostate Cancer discovery stage pipeline products
Prostate Cancer pipeline products short-term launch highlights